ICON plc/$ICLR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Ticker

$ICLR
Primary listing

Industry

Life Sciences Tools & Services

Headquarters

Dublin, Ireland

Employees

41,250

ISIN

IE0005711209

ICON plc Metrics

BasicAdvanced
$12B
16.38
$9.19
1.24
-

What the Analysts think about ICON plc

Analyst ratings (Buy, Hold, Sell) for ICON plc stock.

Bulls say / Bears say

ICON plc's full integration of Medidata Clinical Data Studio enhances data management and review processes, potentially improving operational efficiency and client satisfaction. (stocktitan.net)
The company's expansion of its artificial intelligence tools portfolio aims to deliver efficiencies across the clinical trial process, including study startup and resource forecasting, positioning ICON as a leader in innovative clinical research solutions. (iconplc.com)
ICON's appointment of a new Chief Operating Officer, Barry Balfe, in December 2024, is expected to strengthen its leadership team and drive strategic growth initiatives. (iconplc.com)
A 20% stock price decline in October 2024, following a significant revenue shortfall and reduced annual revenue guidance, has led to a securities fraud investigation, potentially impacting investor confidence. (globenewswire.com)
Analysts have flagged downside risks to ICON's growth projections, leading to a neutral stock rating, which may affect future stock performance. (investing.com)
The company's first-quarter 2025 revenue of $2 billion missed analyst expectations, indicating potential challenges in meeting market forecasts. (thetelegraph.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.

ICON plc Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ICON plc Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ICLR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs